Altuğ T., Şentürk A., Alışık M., Biçer C.
JOURNAL OF HEALTH SCIENCES AND MEDICINE, vol.5, no.3, pp.861-867, 2022 (TRDizin)
Abstract
Introduction: To investigate factors which could possibly be prognostic, to decide on thrombolytic therapy as soon as possible, and to determine the prognostic value of H-FABP, which is a new marker, in pulmonary thromboembolism.
Material and Method: In our study, a patient group, consisting of 58 patients diagnosed with PTE and a control group of 30 healthy individuals were investigated. According to their risk of mortality, patients were analyzed in three groups: high, moderate and low. The moderate mortality risk groups were categorized into two groups according to PAP and patients with PAP≥45 mmHg were “Group 1” and PAP